158 results
Page 6 of 8
8-K
EX-99.2
2ymjo
28 Jun 12
Regulation FD Disclosure
12:00am
424B5
1siqtft mvb
3 May 12
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
6k7bwuow tp1
6 Jan 12
Synta Pharmaceuticals Prices Public Offering of Common Stock
12:00am
424B5
82rxe0y
6 Jan 12
Prospectus supplement for primary offering
12:00am
424B5
2ux7g
5 Jan 12
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
zs0heepe9b8
6 Jun 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
EX-99.1
xxxq5lbrt6fpmv4
15 Sep 10
Synta Announces Expansion of Phase 2 Trial for STA-9090 in Non-Small Cell Lung Cancer Based on Encouraging Clinical Activity
12:00am
8-K
EX-1.1
tpk46 si6
8 Jan 10
Synta Pharmaceuticals Prices $25 Million Public Offering of Common Stock
12:00am